NascentPEP Polypeptide Duan-Chi Tablet
Natural health product licensed in Canada
- Other names
- Dissipation Tablet
- Licence holder
- Nascent Peptide Biotechnology Limited
- NPN or DIN-HM
- 80078263
- Status
- Inactive licence
- Licence date
- 8 June 2017
- Revision date
- Not provided
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Phytostérols Source : Glycine max - Graine | 80 milligramme | Not calculated |
| L-arginine Source : Monohydrochlorure de L-arginine | 270 milligramme | Not calculated |
| Grifola frondosa Source : En entier Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 350 milligramme | 35 milligramme | Not calculated |
| Wolfiporia extensa Source : Sclerotium Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 350 milligramme | 35 milligramme | Not calculated |
Non-medicinal ingredients
Collagène hydrolysé, Stéarate de magnésium, Farine de maïs, Dioxyde de silicium, Extrait de Momordica charantia, Sorbitol, Noyer commun
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 3 Comprimé | 2 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Used in Herbal Medicine to support the immune system. Source of fungal polysaccharides with immunomodulating properties. L-Arginine is a non-essential amino acid that is involved in protein synthesis.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
Hypersensitivity/allergy can occur; in which case, discontinue use. Diuretic effect may occur. Some people may experience gastrointestinal discomfort (such as diarrhea).
- Précautions et mises en garde
Consult a health care practitioner prior to use if you are pregnant or breastfeeding. Consult a health care practitioner if your cardiovascular condition worsens. Consult a health care practitioner prior to use if you have a renal/kidney disease or if you are following a low protein diet. Consult a health care practitioner prior to use if you suffer from a cardiovascular disease and are attempting an increase in physical activity. Consult your health care practitioner prior to use if you are taking medication for cardiovascular diseases, erectile dysfunction, and/or blood thinners. If you have diabetes, consult a health care practitioner prior to use.
- Contre-indications
Do not use if you have had a heart attack/myocardial infarction.
Source
Official Health Canada record, licence 80078263
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.